Prostate Cancer Management: Introduction and Overview
Published Online: Wednesday, December 12, 2012
For High-Definition, ClickIn the first installment of the series, the moderator, Raoul S. Concepcion, MD, provides an overview of the prostate cancer treatment continuum and introduces the panel, which includes: Steve Dobbs, Bryan A. Mehlhaff, MD, Neal D. Shore, MD, and Daniel R. Saltzstein, MD.
This panel discussion seeks to address a range of challenges facing the treatment of men with prostate cancer. Panelist will discuss a range of topics, from data on the many new treatments for prostate cancer to reimbursement and other practice management issues.
Concepcion provides a summary of the current treatment continuum for men with prostate cancer. He explains that androgen deprivation therapy (ADT) is still used as the early treatment for advancing prostate cancer in patients who have failed definitive therapy. In general, ADT lowers androgen levels and stops the growth of prostate cancer cells. However, patients will eventually fail ADT, which manifests in a raise in PSA levels. Following the failure of hormonal therapy, urologists have traditionally referred patients to medical oncologists.
View More From This Discussion
Steve DobbsCEO, Urologic Associates of Oklahoma,
Bryan A. Mehlhaff, MDPrincipal Investigator, Division of Clinical Research, Oregon Urology Institute, Springfield, Oregon
Neal D. Shore, MDDirector, CPI, Carolina Urologic Research Center, Grand Strand Urology/Atlantic Urology Clinics, Myrtle Beach,
Daniel R. Saltzstein, MDMedical Director, Urology San Antonio Research, San Antonio, Texas
Online CME Activities
Most Popular Right Now
The content contained in this video is for general information purposes only. The viewer is encouraged to confirm the information presented with other sources. OncLiveTV Peer Exchange makes no representations or warranties of any kind about the completeness, accuracy, timeliness, reliability, or suitability of any of the information, including content or advertisements, contained in this video and expressly disclaims liability for any errors and omissions that may be presented in this video. OncLiveTV Peer Exchange reserves the right to alter or correct any error or omission in the information it provides in this video, without any obligations. OncLiveTV Peer Exchange further disclaims any and all liability for any direct, indirect, consequential, special, exemplary, or other damages arising from the use or misuse of any material or information presented in this video. The views expressed in this video are those of the panelists and do not necessarily reflect the opinion or policy of OncLiveTV Peer Exchange.